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INTRODUCTION
Fertilization and early embryo development take place in the oviduct in vivo. Relative
to studies in other reproductive organs, the importance of the oviduct has been
ignored for many years because pregnancies can be obtained in assisted reproduction
treatment using in-vitro fertilization (IVF) and embryo transfer to the uterus without
involving the Fallopian tube. After the reports on the bene®cial effect of oviductal
cells on embryo development in sheep1 and subsequently in human,2 and a practical
need to improve the success rates in clinical assisted reproduction, there was a period
when more research was performed on the Fallopian tube. Many of these studies used
in vitro coculture systems to emulate the in vivo environment in vitro, and to search
for oviduct-derived embryotrophic factors. With the recent development of sequential
culture3 to improve embryo development in vitro, the use of coculture in assisted
reproduction and its related research declined because routine use of coculture is
laborious and experience-dependent.
Despite this, evidence is now accumulating to suggest that this organ is not a
passive conduit for gametes and embryos. Before fertilization, it is well accepted that
the oviduct serves as a sperm reservoir in several animal species.4,5 Although there is
no direct evidence for such a function in human Fallopian tube in vivo, in vitro
experiments have demonstrated that human spermatozoa bind to the tubal epithelial
cells.6 In addition, human oviductal cells affect sperm functions in vitro.7-9 After
fertilization, the oviduct provides the microenvironment for early embryonic develop-
ment. This review intends to provide an update on this postfertilization role of the
oviduct, with a particular emphasis on human reproduction.
There is only limited evidence to show which of the oviductal changes are
important for embryonic development because it is dif®cult to change each of these
parameters independent of the others in vivo and to study the effect of such changes
on embryo development. Moreover, the effect of the oviduct on embryo development
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Table 1 Expression of growth factors/cytokines and their receptors in human Fallopian tube and embryos
Growth factor/ Oviduct Oocyte stage 2-cell stage 3- to 4-cell 6- to 8-cell Morula Blastocyst
cytokines & stage stage
receptors
IGF1 +t21,p19,21,94 7t20 7t20 7t144 7t20,144 7t20,144
IGF2 +p19 +t20 +t20 +t20,144,p18 + p18 +t20,144,p18,18
Insulin R +t20 7t20 +t20,144 +t20,144
IGF1 R +p19,94 +t20 +t20 +t20 +t20,p21
IGF2 R +p19 +t20 +t20 +t20 +t20
IGFBP-1 ?t145; +p94 7t144 +t144
IGFBP-2 +t145,p94,145 +t144 +t144
IGFBP-3 +t145,p94,145 +t144 +t144
IGFBP-4 +t145,p94 +t144 +t144
IGFBP-5 7t144 +t144 +t144
IGFBP-6 7t144 7t144 7t144
TGFb +t146,p146 +p147
TGFb-RI +t148,p148 7t148 7t148 7t148 +t148
TGFb-RII +t146,p146 +t148,p148 7t148 7t148 7t148 7t148
Smad2/3 +t148,p148 +t148 +t148 +t148 +t148
Inhibin a 7p149 7t150 7t150 7t150 7t150 7t150
Activin +t150,p150 7t150 7t150 7t150 7t150 +t150
Activin IR 7t150 +t150 7t150 7t150 +t150
Activin IIR +t150 +t150 +t150 +t150 +t150
Follistatin 7t150 7t150 +t150 +t150 +t150
TGF-a +t14,15,74,151,p14-16,151-153 +t154,p154 +p16, +t154,p16,154 +t154,p18,18,154
EGF +t14,15,74,107,151,153,p14,15,151,153 +t154,p154 +t154,p154 +t154,p154
EGF-R +t17,74,151,153,p16,17,151 +p16 +p16
GM-CSF +t90,p90
GM-CSF-R +t90
VEGF +t155
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PDGF-a and -b +t156 7t156 +t156 +t156 +t156
PDGFR-a and -b 7t156 +t156 +t156 7t156 +t156
IL-1a +p157 +p147,158
IL-1b +p159 +t160,p161 +t160,p161,161 +t, 160, p161 +t160,p161 +t160,p161
IL-1R tI +t160,p161 +t160,p161 +t160,p161 7t160,p161 +t160,p161
IL-1ra +p159 +t160,p161 +t160,p161 +t160,p161 +t160,p161 +t160,p161
CSF +t107 7t162,p163 7t162,p163 7t162,p163 7t162 7t162
CSF R 7t162 7t162 7t162 7t162 7t162
LIF +t107,p159 7t162 7t162 7t162 7t162 7t162
LIF-R +t164 7t162 7t162 7t162 7t162 +t162,164,165
+t164 +t164 +t164
IL-6 +t107 +p163 +p163 +p147,163 +t162
IL-6R +t162
c-fms +t162 +t162 +t162 7t162 +t162
TNF-R p80 +t162 +t162 7t162 7t162 7t162
TNF-R p60 7t162 7t162 +t162 7t162 +t162
TNF-a +p159 7t162 +t162 7t162,p163 +t162 7t162
c-kit +t162 +t162 +t162 7t162 +t162
SCF +t162 7t162 +t162 +t162 7t162
gp130 +t164 7t162 +t162 7t162 +t162 +t162
t, transcript; p, protein; +, detectable; -, undetectable; ?, barely detectable; blank space, no information available.
IGF, insulin-like growth factor; R, receptor; IGFBP, insulin-like growth factor binding protein; TGF, transforming growth factor; EGF, epidermal growth
factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; VEGF, vascular endothelial growth factor; PDGF, platelet-derived growth factor;
IL, interleukin; IL-1ra, Interleukin-1 receptor antagonist; CSF, colony stimulating factor; LIF, leukaemia inhibitory factor; c-fms, colony stimulating factor
receptor; TNF, tumor necrosis factor; c-kit, stem cell factor receptor; SCF, stem cell factor; gp130, a component of LIF and IL-6 receptor.
Reference numbers are shown in superscript.
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is facilitatory and not obligatory, making the detection of oviductal embryotrophic
effects more dif®cult. Nevertheless, there is circumstantial evidence mainly from
animal studies showing that the oviduct plays a fundamental role in early embryo
development. This evidence is reviewed below.
CYCLICAL CHANGE OF OVIDUCTAL ACTIVITY
Changes in the ciliated and secretory cells of the primate oviduct are well
documented across the reproductive cycle.10 These changes are regulated by steroids,
such that estrogen induces hypertrophy, maturation and an increase in cell height of
nonciliated secretory oviductal epithelial cells and can partially restore ciliated
phenotype in vitro.11 These, together with cyclical morphological and physiological
variations in the uterus, suggest that these two organs are actively involved in early
reproductive events, and that they offer a dynamic microenvironment for the
development of preimplantation embryos.
The presence of growth factors in the oviduct and the corresponding receptors in
the preimplantation embryo or vice versa suggests possible mechanisms of interac-
tion between the oviduct and the embryo. The expression of growth factors in the
preimplantation embryo and oviduct has recently been reviewed.12,13 Table 1 updates
their occurrence in human oviduct and preimplantation embryos at protein and
mRNA levels. Many of the growth factors in the oviduct are produced in a cyclical
manner. Epidermal growth factor (EGF)/transforming growth factor-a (TGF-a) and
their receptors have been extensively studied in the Fallopian tube and human
embryo. The mRNA and protein expression of EGF and TGF-a are intense in the
ampullary epithelium at late follicular and luteal stages but weak at the early
follicular stage.14,15 Their receptor (EGFR) at the protein level is present in 8- to 14-
cell embryos.16 On the other hand, EGFR is also found in the Fallopian tube with an
expression pattern similar to its ligands.17 Human embryos also secrete TGF-a into
the culture medium; the secretion increases as the embryos develop to morula and
blastocyst.18 A similar situation exists for the insulin-like growth factor (IGF) system,
with expression of the ligand and receptor found in both the Fallopian tube and the
early embryo.16,19,20 Although the addition of some of these factors stimulates
embryo development in vitro,21 it is uncertain whether these signaling systems are
performing paracrine and/or autocrine function in vivo.
OVIDUCTAL MICROENVIRONMENT AND EMBRYO DEVELOPMENT
It is generally accepted that the oviduct may have evolved to provide an optimum
microenvironment for early embryo development. An early preimplantation embryo
is bathed in oviductal ¯uid. Therefore, knowledge on the content of the oviductal
¯uid is important. The composition of oviductal ¯uid has been reported in many
animal species. Interested readers are referred to reviews by Leese,22 Hamner and
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Table 2 Reported composition of oviductal ¯uids in human and primates
Components Species Cycle Concentration Reference
Glucose Human Follicular 3.11 mM 36
Midcycle 0.50 mM
Luteal 2.32 mM
Different stages 1.1 mM 166
Different stages 0.53 mM 167
Pyruvate Human Different stages 0.24 mM 36
Different stages 0.14 mM 166
Different stages 0.17 mM 167
Lactate Human Follicular 4.87 mM 36
Midcycle 10.50 mM
Luteal 6.19 mM
All stages 5.85 mM 166
All stages 8.58 mM 167
Aspartic acid Human Proliferative 17 mM 166
Secretory 41 mM
Glutamic acid Human Proliferative 71 mM 166
Secretory 111 mM
Asparagine Human Proliferative 63 mM 166
Secretory 28 mM
Serine Human Proliferative 26 mM 166
Secretory 38 mM
Glutamine Human Proliferative 24 mM 166
Secretory 51 mM
Arginine Human Proliferative 151 mM 166
Secretory 237 mM
Glycine Human Proliferative 32 mM 166
Secretory 37 mM
Threonine Human Proliferative 44 mM 166
Secretory 47 mM
Alanine Human Proliferative 84 mM 166
Secretory 139 mM
Tyrosine Human Proliferative 24 mM 166
Secretory 49 mM
Tryptophan Human Proliferative 12 mM 166
Secretory 18 mM
Methionine Human Proliferative 12 mM 166
Secretory 14 mM
Valine Human Proliferative 22 mM 166
Secretory 32 mM
Phenylalanine Human Proliferative 16 mM 166
Secretory 18 mM
Isoleucine Human Proliferative 17 mM 166
Secretory 20 mM
Leucine Human Proliferative 50 mM 166
Secretory 67 mM
Lysine Human Proliferative 42 mM 166
Secretory 61 mM
Sodium Human Preovulatory 140±142 mM 26,27
Postovulatory 139±148 mM 26,27
Different stages 130 mM 168
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Fox,23 and Menezo and Guerin.24 Recently, Leese and coworkers25 provided an
excellent review on the formation of oviductal ¯uid. It is not the intention of this
article to review all the components reported in the oviductal ¯uid. Table 2 contains
some of the reported compositions of oviductal ¯uid from humans and primates.
Similar to many other species, the oviductal ¯uid in the primate is rich in K+ and
HCO3
± when compared with plasma.26±28 Estrogen appears to stimulate the produc-
tion of oviductal ¯uid, as the greatest volume of oviductal ¯uid in human and
monkeys was observed at midcycle, coincident with the estrogen peak.29,30 It has
been suggested that estrogen may modulate the movement of ions across the
oviductal epithelium and, thereby, in¯uence the rate of ¯uid secretion.25 These data
are consistent with an active regulation of oviductal function at the time of
fertilization and early embryo development.
The nutrient requirement of the embryo changes as it grows. The importance of
amino acids and nutrients to early preimplantation embryo development has been
critically reviewed.31,32 Similar to many other animal species, human embryos
consume pyruvate throughout the preimplantation period, and they use an increasing
amount of glucose at compaction and blastocyst formation.33,34 In fact, a high level of
glucose inhibits early embryonic development in a number of species including
human.35 The concentrations of nutrients in the oviduct differ from those in plasma,
and vary with the endocrine state.36 The concentration of glucose in human Fallopian
tube ¯uid decreases sixfold between the follicular phase and midcycle.36 It was
speculated that the decrease in glucose concentration of oviductal ¯uid from mated
pig when compared to unmated pig37 was a strategy of the oviduct to protect embryos
from exposure to a high concentration of glucose.34 The importance of optimal
Table 2 continued
Components Species Cycle Concentration Reference
Chloride Human Preovulatory 119±127 mM 26,27
Postovulatory 112±117 mM 26,27
Different stages 132 mM 168
Potassium Human Preovulatory 6.7±9.9 mM 26,27
Postovulatory 6.7±7.7 mM 26,27
Different stages 21.2 mM 168
Calcium Human Preovulatory 1.89 mM 26
Postovulatory 2.37 mM 26
Different stages 1.13 mM 168
Magnesium Human Preovulatory 0.53±0.69 mM 26
Different stages 1.42 mM 168
pH Rhesus monkey Follicular 7.1±7.3 28
Ovulation & luteal 7.5±7.8
Bicarbonate Rhesus monkey Follicular 35 mM 28
Luteal 90 mM
pO2 Rhesus monkey Follicular <10 mmHg
169
Follicular 35 mmHg 170
Ovulation & luteal 57±61 mmHg
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nutrient concentrations is also re¯ected in experiments on sheep38 and mouse39
showing that embryo culture media based on nutrient concentrations in oviductal
¯uid are superior to conventional media in supporting embryo development in vitro.
Similarly, the embryo has a differential requirement for amino acids at different
stages of development,40 and media based on the amino acid content of oviductal
¯uid improve ovine blastocyst formation and hatching.41
Apart from simple organic and inorganic molecules, the oviduct synthesizes and
releases a number of macromolecules. Interested readers are referred to reviews by
Buhi and coworkers.42,43 Like many other animal species, the biosynthetic activity of
the Fallopian tube increases at midcycle in the human.43 In pig and sheep, it has been
further shown that biosynthetic activity is higher in the ampulla than it is in the
isthmus.44,45 Some secretory proteins from the human Fallopian tube ¯uid, including
oviduct-speci®c glycoprotein (OGP),46 corticosteroid-binding globulin-like protein,47
and insulin-like growth factor-binding protein 348 may be involved in fertilization and
early embryonic development. Three high molecular weight embryotrophic glyco-
protein fractions that stimulate mouse embryo development49 have recently been
isolated from human-oviductal-cell-conditioned medium.50 The exact identities of
these factors remain to be determined, but it is believed that these molecules are
responsible for maternal-embryonic cross-talk during early preimplantation develop-
ment.51
OGP is one of the major macromolecules secreted by the oviduct. The protein has
been characterized in several species, including rhesus,52 baboon53 and human.54 In
human, OGP is localized to the secretory granules of oviductal cells in both the
ampulla and isthmus regions.55 The human OGP gene54 and its promoter56 have been
cloned and characterized. The presence of OGP around the time of ovulation suggests
that it may play a role in fertilization and/or early embryonic development.46,57 In
hamster, the molecule attaches to the ovulated oocyte and early embryo,46,58,59 and
also associates with the blastomeres.60,61 Although the physiological role of OGP is
unclear, the chitinase-like domains of OGP are believed to interact with the
oligosaccharide moieties of the zona pellucida, thereby forming a protective shield
around the oocyte and early embryo.58
HORMONAL EFFECTS ON OVIDUCTAL EMBRYOS
It is generally believed that progesterone is essential for inducing the changes in the
oviduct and uterus necessary for embryo viability and implantation. Administration
of an anti-progesterone antibody to mice at 32 hours postcoitum retarded embryonic
development; most of the embryos remained at the 4-cell stage whereas the control
embryos were at the 8-cell to morula stage at 54±58 hours postcoitum.62 The antibody
treatment also induced a change in wheatgerm-lectin binding sites in the oviductal
ampulla at days 3 and 4 of pregnancy,63 but did not have noticeable effect on cultured
mouse embryos.62
A similar conclusion was reached using the anti-progestin, RU486, in mice.64,65
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However, the data on RU486 have to be interpreted with caution as this antiprogestin
inhibits the development of mouse embryos in vitro.66,67 RU486 also affects oviductal
embryo transport in this species.68 Using a dose that did not affect the development of
cynomolgus monkey embryos in vitro,69 RU486 administration on day 2 after the
presumed day of ovulation retarded preimplantation embryo growth in rhesus
monkey.70 The retarded embryos had abnormal morphology71 and did not implant
after transfer to naturally synchronized surrogate recipients.70
Apart from progesterone, estradiol may also affect embryo development indirectly
via its effect on oviductal secretion. Two-cell mouse embryos cultured in oviductal
¯uid from estrogen-dominated donors were signi®cantly less able to develop to
morula or blastocyst and to implant than those cultured in either control medium or
the progesterone-dominated oviductal ¯uid.72 No inhibitory effect was observed on
embryo development when estradiol or progesterone was added directly to the control
medium. Estradiol may exert its action by affecting growth factor signalling systems
in the oviduct. It induces oviductal mRNA expression of IGF-I in rat73 and EGF,
TGF-a, and EGF receptor in human.17,74
EFFECTS OF OVIDUCTAL CELLS ON EMBRYO DEVELOPMENT IN VITRO
The above evidence demonstrates that the microenvironment in the oviductal ¯uid
affects early preimplantation embryo development. However, the actual contribution
of the oviductal cells on embryo development is uncertain, as the components in the
oviductal ¯uid can be derived from plasma transudation and not solely from active
secretion from the oviduct. It has been demonstrated that coculture of human
embryos with human Fallopian tube cells improves the quality of the developing
embryos.2,75,75-77 As these studies provide more direct evidence that oviductal cell
activities do contribute to the embryotrophic effect of the oviduct, this aspect is
discussed in greater detail below.
COCULTURE STUDIES IN CLINICAL IVF
There have been a number of clinical coculture trials using oviductal cells of human
or bovine origin in assisted reproduction. Table 3 summarizes the results of these
studies. Most of the studies are prospective randomized clinical trials. Apart from one
study, coculture with oviductal cells improved embryo quality and/or enhanced
pregnancy rate/implantation rate. For some unknown reason, Tucker and coworkers78
found no bene®cial effect of oviductal cells for couples requiring intracytoplasmic
sperm injection (ICSI). However, the indication for ICSI and whether couples were
undergoing IVF for the ®rst time were not mentioned. In addition to the clinical
studies listed in Table 3, there are other in vitro experiments demonstrating that
oviductal cells decreased embryo fragmentation,76 increased blastulation rate,76,79 the
number of cells per blastocyst,79 and the hatching rate of human embryos.75
28 WSB Yeung, CKF Lee and JS Xu
Table 3 Controlled clinical trials using oviductal cells
Somatic Patient Study design Coculture duration* Cocultured embryo Pregnancy/ Reference
cells origin development implantation#
Bovine Non-male factors Prospective randomized 1 day after fertilization Less fragmentation Increase PR and IR 171
More blastomeres
Non-male factors Prospective randomized 1 day after fertilization Less negative Increase PR 172
morphological
characteristics
Young ®rst time IVF; Prospective randomized 2 days after fertilization More blastomeres No difference 83
non-male factors Less fragmentation
Female 38 years; Prospective randomized; 2 days after fertilization More zona thickness Increase PR 80
multiple failed IVF + assisted hatching variability
attempts
Multiple failed IVF Previous IVF as control; 2 days after fertilization More blastomeres Not compared 81
attempts; non-male + assisted hatching Les fragmentation
factor
ICSI patients Prospective randomized 3 days after ICSI No difference No difference 78
Human Non-ICSI Prospective randomized 1 day after fertilization Not compared Increase IR 77
Unselected, non-ICSI Non-randomized 1 day after fertilization Not compared Increase PR/IR** 2
ICSI, intracytoplasmic sperm injection; IR, implantation rate; IVF, in vitro fertilization; PR, pregnancy rate.
* Duration after fertilization check
#When compared with control
** When compared with patients performing conventional IVF in the same period
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It has been suggested that oviductal cell coculture is suitable for poor prognosis
patients, such as patients of advanced age,80 patients with multiple failed IVF
attempts,80,81 and patients with a high basal level of follicle stimulating hormone.82
Coculture may not be required for young (<35 years) ®rst-time IVF patients as there is
no difference in pregnancy rates in these patients with or without coculture, though
the development of the embryos is improved after coculture.83 This group of patients
with a good prognosis is likely to produce suf®ciently good quality embryos that are
competent to development in vitro.
LIMITATIONS OF COCULTURE STUDIES
Although oviductal cell coculture intends to imitate the in vivo condition, this
objective cannot be achieved with the current model because the culture require-
ments of the somatic cells and the embryos are different. In a coculture system, only
one culture medium, commonly the embryo culture medium, is used. Thus, the
somatic cells are grown under suboptimal conditions. Walter84 concluded that
monolayers of bovine oviduct epithelial cells could not fully substitute for the
oviduct epithelium when used in coculture experiments. Thus, cultured somatic cells
may not function optimally in a coculture system.
To improve the ef®ciency of coculture, optimization of coculture conditions is
important. In our experience the best coculture system using human oviductal cells
with Earles' balanced salt solution is when the cells are at the rapidly growing phase.
We usually seed 56104 cells in a 4-well plate and the cells will be ready to use the
next day. Wiemer and coworkers83 reported similar observations with bovine
oviductal epithelial cells. They suggested that con¯uent cells and actively dividing
noncon¯uent monolayers might secrete different levels of embryotrophic factors, and
that steroid treatment affected the plating ef®ciency of bovine oviductal cells.83
Con¯uent oviductal cell culture will cause the detachment and death of epithelial
cells, leading to an increase in the acidity of the medium which is deleterious to
embryo development.
During coculture, the observed effects on embryo development are the conse-
quence of two opposing activities; namely, the embryotrophic effect of somatic cells
and the combined deleterious effect of excretory waste from the somatic cells,
proteases released by the somatic cells as a result of cell death and inappropriate
competition of nutrients between the somatic cells and the embryos. This was shown
in one of our unpublished experiments (Liu LPS and Yeung WSB) in which mouse
embryos were cultured in spent media after culturing the oviductal cells for different
durations and in media containing only the high molecular weight embryotrophic
fraction of the conditioned media. Figure 1 shows the results of the experiment.
Conditioned medium had its maximal embryotrophic effect after 6±9 hours of
conditioning, but became inhibitory after 24 hours. On the other hand, the embryo-
trophic effect of the high molecular weight factors accumulated with time, reaching a
plateau after 6 hours of conditioning. It has been reported that cocultured embryos are
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subjected to dynamic changes of growth factors/cytokines released by Vero cells85
and that the culture condition will affect the secretion of growth factors by the
cells.86
The results of a number of reports on the use of somatic cells other than oviductal
cells for coculture with human embryos are much more variable. Assisted reproduc-
tion without the involvement of the Fallopian tube can give rise to live birth,
indicating that the coculture embryotrophic effect is facilitatory and not obligatory to
embryo development. In many coculture studies, the embryos were cocultured for
only 1±2 days. This short coculture period may not be suf®cient to induce an effect
that can be manifested as an increase in pregnancy rate. The embryotrophic effect is
further diminished when the number of somatic cells available, e.g. granulosa cells, is
limited. Therefore, it is likely to be more dif®cult to demonstrate an increase in
pregnancy rates in these studies.87
Despite the general observation of enhanced embryo development after oviductal
cell coculture, it is not used in most human assisted reproduction programmes
because of the complexity of its implementation as a routine service and the
limitations listed above. In addition, there is risk of transfer of disease from
contaminated cultures to the embryos during coculture.88 A safer and more practical
approach is to produce a chemically de®ned embryo culture system.89 Consequently,
the recent development of the sequential culture, the use of different culture media
for culturing embryos at different stages of development, has rapidly become the
method of choice for improving the outcome in human assisted reproduction
programmes.3
Figure 1 Effect of duration of conditioning of the embryotrophic activity of human oviductal cells on
mouse embryo development. The percentage of blastulation in medium-alone culture was arbitrary
taken as unity. Results of various treatments were expressed as ratios to the control. * P<0.05 when
compared with the control (ANOVA)
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Coculture and sequential culture are not mutually exclusive, and in fact they can
complement each another. The human Fallopian tube produces granulocyte-macro-
phage colony-stimulating factor (GM-CSF) with a peak expression in the preimplanta-
tion period.90 GM-CSF has recently been shown to improve human embryo
development in the G1.2/G2.2 sequential culture medium system.91 Its receptor
mRNA is present in mouse embryos at all stages of development.92 These data
suggest that the present sequential culture system is not yet optimal, and that we can
further improve the system by studying the mechanisms by which oviductal cells
improve embryo development. Indeed, new sequential media may obviate the need
for coculture.
OVIDUCTAL EMBRYOTROPHIC MECHANISMS
The exact mechanisms of oviductal embryotrophic activity in vivo are unclear. Most
of the information in this area is based on in vitro coculture studies. However, the use
of coculture to study oviductal embryotrophic mechanisms in human embryo
development is dif®cult because the availability of human embryos for research is
limited for ethical reasons. Very often mouse embryos are used instead.
Characterization of oviductal embryotrophic mechanisms using coculture faces
two problems. The ®rst is that oviductal cells produce minute amount of embryo-
trophic factors making characterization of these factors dif®cult. The problem is
aggravated as human oviductal cells have a limited proliferative life span in culture,
posing more dif®culty in isolating suf®cient embryotrophic factors. We have recently
established an immortalized human oviductal cell line93 that retains most of the
characteristics of primary oviductal cells including the production of OGP and some
embryotrophic factors. In future, this cell line will be a valuable tool for studying the
interaction between oviductal cells and embryos.
The second problem arises because the actions of oviductal embryotrophic factors
are only facilitatory to embryonic development. In coculture experiments using
mouse embryos, the ability to detect embryotrophic activity is often low because the
development of many mouse strains does not require additional support in standard
culture conditions for blastulation, the usual endpoint in these studies. In order to
increase the sensitivity of detection, we use a mouse strain with low developmental
potential in commonly used mouse culture media to assess the coculture embryo-
trophic effect. With this model, we detect the presence of three embryotrophic
factors, termed ETF-1, -2, -3, in spent medium after human oviductal cell culture.49,50
There are three proposed mechanisms of embryotrophic activity in coculture;
namely, positive conditioning, negative conditioning and cell-to-embryo contact.
Positive conditioning refers to the production of embryotrophic factors by the
somatic cells. During preimplantation embryo development, numerous peptide
growth factors, their corresponding receptors and binding proteins are expressed in
the oviduct of human, mouse and other domestic animals (Table 1). The expression of
many of these growth factors, e.g. IGF-1,19,94 IGF-2,19 TGF-a, EGF14,17 (full names of
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IGF, TGFa and EGF can be found on p. 22), is highest from mid-cycle to the early
luteal phase, a time when the preimplantation embryo is in the oviduct. Many of the
corresponding growth factor receptors are also expressed in the embryos within this
period. Paracrine interaction between the oviduct and human preimplantation
embryos via growth factors is indicated by the observation that addition of growth
factors, e.g. IGF-121, leukaemia inhibitory factor (LIF)95 or heparin binding-epidermal
growth factor,96 to the culture medium facilitates human embryo development in
vitro. Apart from growth factors, OGP binds to the zona pellucida and blastomeres of
hamster embryo,61 suggesting a possible role of this molecule in early embryo
development. Hunter97 proposed that oviduct glycoproteins might increase the
viscosity of luminal ¯uid, thereby preventing the dispersal of essential nutrients and
ions and stabilizing the microenvironment immediately surrounding the embryos.
However, this is dif®cult to test in vivo as the oviduct plays only a facilitatory role in
embryo development.
It is unknown how the embryotrophic factors affect embryo development. When
compared to embryos cultured in medium alone, human oviductal cell coculture
affects the gene expression pro®les of mouse embryos,98 and reduces the incidence of
apoptosis at the morula and blastocyst stage.99 Human19,21,94 and bovine100 oviductal
cells express IGF-1. Exogenous IGF-I improved human embryo development partly by
decreasing the incidence of blastomere apoptosis in the treated embryos,101 leading to
an increase in the number of cells within the inner cell mass.21
Our recent data show that human oviductal cells produce three embryotrophic
factors, ETF-1, -2 and -3 in vitro.50 These factors are unlikely to be common growth
factors as they have much larger molecular sizes. The stimulatory activity of ETF-3
on mouse blastulation is unaffected by antibodies against TGF-a, TGF-b, IGF-II,
IGFBP3 (Xu and Yeung, unpublished observations). These factors have differential
spatial and temporal effects on the development of mouse embryos.102 Thus, ETF-1
and ETF-2 treatment covering the period of 48±72 hours after human chorionic
gonadotrophin injection (hCG) increased cell numbers in the inner cell mass of the
resulting blastocyst, whilst ETF-3 treatment covering 96±120 hours post-hCG
increased the cell number in the trophectoderm. The improved development of
trophectoderm after ETF-3 treatment resulted in larger blastocysts that hatched,
attached to and spread on culture dishes more often than was seen in untreated
controls. These results suggest that the response of embryos to embryotrophic factors
changes as the embryos develop. We are currently investigating whether the response
of the embryos to ETF-3 treatment is affected by prior treatment with ETF-1 and -2. In
this connection, human endometrial stromal cells enhance the expression of IGF
receptors in cocultured human embryos,103 which might then become more sensitive
to subsequent IGF treatment.
It is believed that conventional embryo culture conditions are not optimal.
Negative conditioning refers to the removal of the suboptimal culture condition by
coculture with somatic cells, leading to improved embryo development. The level of
superoxide anion in culture medium is signi®cantly reduced by human oviductal cell
coculture.104 Bovine oviductal cells improve embryo development partly by altering
The oviduct and development of the preimplantation embryo 33
the carbohydrate concentrations in the culture medium.105 However, this embryo-
trophic mechanism is likely to be an artefact in vitro and may not represent the
situation in vivo. Somatic cell-to-embryo contact has been shown to be unimportant
in human oviductal cells coculture.106 However, contradictory observations have also
been reported.104
Although various cell types exert embryotrophic activity on embryonic develop-
ment in vitro, they may act via distinct mechanisms. Different cell types secrete
different growth factors. Human oviductal cells express EGF, LIF, colony stimulating
factor-1 and interleukin-6 (IL-6) while buffalo rat liver cells do not express LIF and
IL-6.107 Vero cells, but not human oviductal cells, improve mouse embryo develop-
ment partly by altering the concentration of nutrients in the culture medium.108
Therefore, it is surprising that the ef®cacy of coculture is different among the somatic
cells used. In cattle, oviductal epithelial cell coculture produces better embryos than
does coculture with granulosa cells,109 oviductal stromal cells or endometrial
epithelial cells.110 The post-transfer development of bovine embryos is also better for
embryos after coculture with oviductal cells than it is with those after coculture with
bovine fetal uterine ®broblasts.83 Although both sheep oviductal cells and ®broblast
coculture stimulate embryo development in vitro, the development of sheep embryos
after transfer following oviductal coculture is superior to that of embryos after
®broblast coculture.1 Similarly, we also found that human oviductal epithelial cells
were better than oviductal ®broblast in enhancing mouse blastulation.49 In a
prospectively randomized study, coculture with human ®broblasts did not improve
embryo quality and pregnancy rate when compared to conventional medium alone.111
EFFECTS OF EMBRYO ON OVIDUCTAL ACTIVITY
Most of the coculture studies investigate the effect of oviductal cells on embryo
development. There are some reports demonstrating that the embryos also affect
oviductal physiology in animals. Although similar reports of humans are lacking, the
machinery for such interaction has been demonstrated in human oviduct and
embryos, suggesting that similar activity may also be present.
In mice, the vasculature of the oviduct containing 2-cell embryos is different to
that in pseudopregnant mice without embryos.112 Platelet activating factor (PAF) may
be involved in these vascular changes.112 PAF is produced by early embryos from a
number of species including mouse,113,114 sheep115 and human.116 It alters several
aspects of the maternal physiology during early pregnancy including systemic platelet
count (inducing thrombocytopenia116) and endometrial prostaglandin secretion.117
The presence of the PAF receptor has recently been reported in human Fallopian
tube118 and bovine oviduct.119 PAF increases the potential difference and short-circuit
current when applied to the apical surface of human oviduct120 and increases the
intracellular free calcium concentration121 and proliferation122 in bovine oviductal
cells in culture.
Fertilized embryos are transported down the oviduct at a faster rate than
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unfertilized ova in hamsters,123 rat,124 bats 125 and mares.126 Evidence suggests that
the development of embryos in¯uences the timing of their entrance to the uterus in
the rat.124 Equine embryos secrete prostaglandin E2 immediately before and during
the expected time of transport from oviduct to the uterus.127 Prostaglandin E2 has
been shown to hasten this transport in the mare.128 In hamsters, PAF stimulates
oviductal transport of embryos,129 probably by stimulating the frequency of the
ciliary beat in oviductal cells.130,131 Similar data are not available for humans.
TGFb-1 mRNA expression in mice is high in the 8-cell embryo and morula, but
drops signi®cantly at the blastocyst stage.132 However, the functional receptor for this
growth factor can only be detected in the blastocyst. This suggests that the production
of TGFb-1 by the early embryo before compaction may be relevant to its paracrine
action on the oviduct. This is supported by our detection of TGFb-1 receptor
expression in the oviduct throughout preimplantation embryo development. There
are also indications that intra-oviductal embryos can exert a biological effect on the
uterus, enhancing endometrial receptivity.133 It is unlikely that an oviductal embryo
with a few blastomeres is able to produce suf®cient quantities of active components
to affect the physiology of other organs. In fact, embryo-derived PAF has a systemic
effect on thrombocytopenia in early pregnancy.134 It is more likely that embryo-
derived factors affect the nearby oviductal cells, which amplify the embryonic signal
and modify the physiology of the maternal system. Embryos have been shown to
stimulate the production of IGFBP-3 by human oviductal cells.48 A similar conclusion
was reached in a mouse embryo/human endometrial cell coculture system.135
CONCLUSION
The reproductive tract creates a dynamic environment for the optimal development
of mammalian embryos in vivo. In nature, all embryos are exposed to the oviductal
microenvironment after fertilization. Data suggest that the oviductal environment is
important for the development of embryos and that there is complex cross-talk
between embryos and the oviduct. The best available medium today contains only a
small subset of the components present in the oviductal environment. Although the
embryo can adapt to its environment,34,136 the inadequacy of the medium inevitably
causes stress to the cultured embryos.137 This may be one reason for the low success
rate in clinical assisted reproduction. To improve this situation, improved knowledge
of the oviductal microenvironment is crucial. Unfortunately, information on this
aspect is rather limited.
Coculture is a good model, though with some pitfalls, for giving clues to the
possible mechanisms of interaction between the embryo and the oviduct. Its
utilization in clinical assisted reproduction has generated some controversy.138,139
The arguments against its use include the fact that coculture is not chemically
de®ned, making interpretation dif®cult, and coculture embryotrophic effects may
only represent a remedy for artefacts created by conventional suboptimal culture
conditions.89,140 The pursuit of speci®c oviduct factors in coculture and the con®rma-
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tion of the embryotrophic activity by adding these factors to chemically de®ned
medium would help to solve the controversy. Future work should focus on the
normal physiology and biochemistry of the oviduct and the early embryo.
A word of caution for the supplementation of only some embryotrophic factors to
the embryo culture medium is necessary. Some embryotrophic factors have speci®c
effects on certain cell types of embryos. For instance, ETF-3 affects mainly trophecto-
derm cells. The effect of a selective increase in the development of trophectoderm on
subsequent fetal development remains to be determined. In this context, it has been
reported that larger calves are born after coculture with tubal cells,141,142 and that the
percentage of male calves is increased after coculture with bovine oviduct epithelial
cells and Vero cells.143 Rigorous controlled studies will be necessary before suggesting
the application of media supplemented with embryotrophic factors to clinical assisted
reproduction.
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